read
interest
recent
letter
hao
address
initi
neg
rtpcr
result
atyp
patient
sinc
outbreak
unexplain
pneumonia
case
wuhan
china
decemb
coronaviru
diseas
spread
countri
march
infect
influenc
patient
global
recommend
world
health
organ
posit
realtim
revers
transcriptas
polymeras
chainreact
rtpcr
result
could
confirm
diagnosi
suspect
patient
howev
still
lack
thoroughli
research
concern
viral
shed
time
among
differ
sam
ple
patient
compar
viral
shed
time
differ
sampl
intens
care
unit
icu
nonicu
patient
analyz
characterist
analyz
total
thirtytwo
patient
admit
central
hospit
xiangtan
januari
februari
dynam
clinic
sampl
includ
nasal
swab
blood
fecal
urin
saliva
tear
collect
patient
surveil
record
synchron
clinic
epidemiolog
inform
oral
consent
total
rna
extract
clinic
sampl
perform
rtpcr
test
target
continu
variant
describ
mean
conform
kolmogorovsmirnov
test
analysi
chisquar
test
mannwhitney
test
compar
differ
among
group
p
consid
signific
statist
analys
figur
conduct
use
stata
graphpad
prism
tabl
thirtytwo
patient
includ
eight
icu
twentyfour
nonicu
patient
age
rang
year
old
proport
patient
wuhan
none
come
back
citi
hubei
provinc
three
patient
hubei
provinc
infect
peopl
hubei
nine
thirtytwo
patient
identifi
famili
cluster
infect
seven
patient
clear
contact
histori
enrol
patient
carri
underli
diseas
common
diseas
hypertens
patient
diabet
patient
averag
onset
day
five
day
common
initi
symptom
cough
surprisingli
patient
present
fever
begin
symptom
encompass
fatigu
headach
diarrhea
sore
throat
muscular
sore
anhel
four
patient
diagnos
without
symptom
abbrevi
coronaviru
diseas
sever
acut
respiratori
syndrom
coronaviru
rtpcr
realtim
revers
transcriptas
polymeras
chainreact
world
health
organ
icu
intens
care
unit
indic
rtpcr
result
obtain
posit
rate
viral
shed
time
differ
sampl
icu
nonicu
patient
posit
rate
nasal
swab
patient
three
patient
experienc
neg
result
first
test
posit
rate
saliva
significantli
higher
tear
enrol
patient
p
urin
sampl
thirtytwo
patient
neg
test
blood
posit
rate
icu
nonicu
patient
respect
perform
consecut
analys
nasal
swab
blood
saliva
nonicu
icu
group
shown
fig
viral
shed
posit
neg
time
nasal
swab
significantli
longer
blood
p
saliva
p
though
shorter
time
viral
shed
blood
sampl
saliva
observ
signific
p
valu
detect
p
viral
shed
time
nasal
swab
day
nonicu
group
day
icu
group
blood
viral
shed
time
day
nonicu
icu
patient
respect
saliva
nonicu
icu
patient
took
day
separ
convers
neg
shown
fig
b
nasal
swab
nonicu
patient
significantli
shorter
icu
patient
p
obviou
signific
indic
blood
saliva
sampl
nonicu
icu
group
rtpcr
wide
use
tool
diagnos
infect
guid
two
consecut
neg
rtpcr
result
least
two
day
apart
achiev
discharg
patient
sever
case
report
neg
rtpcr
test
confirm
studi
one
patient
experienc
five
continu
neg
result
admiss
sixth
nasal
swab
admiss
final
support
diagnosi
consid
situat
molecular
diagnosi
made
clinic
sampl
etiolog
test
includ
serolog
test
crispr
metagenom
sequenc
viral
shed
time
report
around
two
week
longer
time
consum
turn
posit
neg
nasal
swab
blood
saliva
sampl
accord
respiratori
transmiss
characterist
diseas
indic
longer
surveil
need
respiratori
sampl
nucleic
acid
test
studi
categor
patient
two
group
icu
nonicu
icu
patient
viral
shed
time
blood
nasal
saliva
sampl
exceed
two
week
illustr
rel
longer
period
nonicu
patient
differ
viral
shed
time
icu
nonicu
patient
might
correl
viru
load
sever
invas
oper
patient
conclus
studi
origin
illustr
nasal
swab
sampl
consum
time
turn
neg
blood
saliva
sampl
viral
shed
time
icu
patient
longer
nonicu
patient
especi
nasal
swab
sampl
combin
test
differ
sampl
might
provid
us
inform
concern
transmiss
characterist
patient
author
report
potenti
conflict
interest
